Chloroquine is a drug belonging to the aminoquinoline family that is widely used for treating diseases such as lupus, cancer, and malaria. In this sense, the present work describes the development of a simple method based on electrogenerated chemiluminescence (ECL) and a screen-printed carbon electrode (SPE) modified with carbon black for chloroquine determination. The carbon black modified SPE was characterized by scanning electron microscopy, Raman spectroscopy, cyclic voltammetry and linear sweep voltammetry to obtain the ECL-potential curves. The ECL method is based on the chemiluminescence resulting from the interaction between chloroquine and the tris(2’2-bipyridyl) ruthenium(II) complex. Under optimized experimental conditions, the method showed a wide linear working range between 0.5 and 500 µmol L-1. The method presented good precision and accuracy in drug samples used in the treatment of malaria and artificial urine sample, showing recovery values from 100 to 103% and 99 to 103%, respectively.

This work describes the development of a platform based on bismuth oxyiodide (BiOI), sulfur-doped graphitic carbon nitride (S-g-C3N4), and bismuth-doped sodium tantalate perovskite (Bi-NaTaO3) for zero-biased photoelectrochemical immunosensing of cardiac troponin I (cTnI) biomarker. The spectroscopic, structural, morphological, and compositional characteristics of the photoelectrochemical (PEC) materials were evaluated by Raman and Fourier-transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), scanning electron microscopy (SEM), and energy-dispersive X-ray spectroscopy (EDS). Electrochemical impedance (EI) measurements were performed under the incidence and absence of light to investigate the effects of photons on the charge transfer resistance of the photoelectrochemical platform. The influence of the cTnI biomarker on the photoelectrochemical response of the anti-cTnI antibody-modified photoelectrochemical platform (anti-cTnI/BiOI/S-g-C3N/Bi-NaTaO3/FTO) was evaluated by measuring the photocurrent of the system. The immunosensor presented a linear response range from 1 pg mL 1 to 50 ng mL 1, mean recovery percentage between 95.98 and 99.78% in real human serum samples, and selectivity for the cTnI biomarker.

The present work is based on the development and application of a photoelectrochemical method for the amperometric determination of 3,4,5-trihydroxybenzoic acid in different samples. The method is based on the use of a photoelectrochemical platform based on a glass slide coated with fluorine-doped tin oxide, which has been modified with cadmium sulfide and poly(D-glucosamine) and subjected to a light-emitting diode (LED) lamp. The photoelectrochemical platform was sensitive to the increase of the concentration of the antioxidant 3,4,5-trihydroxybenzoic acid in the solution. Under the optimized experimental conditions, the photoelectrochemical method presented a linear response for a 3,4,5-trihydroxybenzoic acid concentration ranging from 0.2 up to 500 µmol L-1. The method was applied to 3,4,5-trihydroxybenzoic acid determination in samples of wines and teas with recoveries between 95.88 and 101.72%. The results obtained suggest that the developed platform is a promising tool for quantifying the 3,4,5-trihydroxybenzoic acid.

This work describes the development of a photoelectrochemical sensor for glucose quantification exploiting a light assisted-batch injection analysis (BIA) cell. A light-emitting diode (LED) lamp was employed to control the incidence of light on the p-Cu2O/n-Cu2O/fluorine-doped tin oxide (FTO) photoactive platform in BIA cell. The p-Cu2O/n-Cu2O/FTO platform was constructed by electrodepositing n-Cu2O and p-Cu2O and the characteristics of electrodeposited Cu2O films were investigated by X-ray diffraction (XRD), Raman spectroscopy, and electrochemical impedance spectroscopy. The light assisted-batch injection analysis of glucose based on the illuminated p-Cu2O/n-Cu2O/FTO photoelectrode presented a linear response of 10 μmol L-1-1 mmol L-1, a limit of detection of 4.0 μmol L-1, and sensitivity of 0.768 ± 0.011 μA L μmol-1 cm-2. The system presented an average recovery value of 96% when applied to the determination of glucose in an artificial saliva sample, which indicates that the incidence of light on photoelectroactive platforms is a promising approach for the determination and quantification of glucose.